Geron | GERN - Actif À Court Terme

Prix De L'Action
1.67
Variation Quotidienne
-0.09 -5.11%
Mensuellement
0.60%
Annuel
21.01%
Q2 Prévisions
1.62




Actif À Court Terme Changement Date
Amgen USD 29.06B 1.17B 2025-12
Bio Techne USD 637.43M 27.92M 2025-12
Cassava Sciences USD 97.71M 11.2M 2025-12
Cytokinetics USD 916.97M 60.37M 2025-12
Esperion Therapeutics USD 462.57M 102.11M 2025-12
Exelixis USD 1.44B 41.03M 2025-12
Genmab DKK 2.88B 1.59B 2025-12
Geron USD 520.27M 2.07M 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
Incyte USD 5.02B 746.01M 2025-12
MacroGenics USD 219.94M 12.15M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Novavax USD 978.28M 3.69M 2025-12